BioSpace News Archive

Pharm Country

Air Products Declares Quarterly Dividend

May 18, 2011
·
1 min read
Drug Development

Pfizer Inc.'s Anti-TNF-Alpha Nanobody (ATN-103) Successfully Completes a Phase II Study and Demonstrates Clinical Proof-of-Concept (POC) in Patients With RA

May 18, 2011
·
2 min read
Business

Patheon Announces Date Of Second Quarter Fiscal 2011 Financial Results

May 18, 2011
·
2 min read
Drug Development

Amgen’s XGEVA Phase 3 Trial Meets Primary Endpoint

May 18, 2011
·
13 min read
Pharm Country

Quest Diagnostics Inc. Declares Quarterly Cash Dividend

May 18, 2011
·
1 min read
Business

Goodwin Biotechnology, Inc. and RAFAGEN Announce a Collaboration

May 18, 2011
·
2 min read
Deals

Quest Diagnostics Inc. Successfully Completes Acquisition of Celera

May 18, 2011
·
1 min read
Genetown

Curis, Inc. to Present at the 2nd Annual ThinkEquity Healthcare Conference

May 18, 2011
·
1 min read
Genetown

Seaside Therapeutics Publishes Review of Advances in the Treatment of Fragile X Syndrome in American Chemical Society Chemical Neuroscience

May 18, 2011
·
1 min read
Genetown

Sunovion Pharmaceuticals Inc. Release: Latuda(R) (lurasidone HCl) was Associated with Low Rates of Weight Gain and Metabolic Changes in Patients with Schizophrenia in Data Presented at the 164th Meeting of the American Psychiatric Association

May 18, 2011
·
1 min read